Noticias y notas de prensa
Manténgase al día con las noticias y los eventos de la Asociación.
Acceso Rápido
Notas de Prensa
Comunicados PPTA
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PPTA Statement on the Revision of the General EU Pharmaceutical Legislation
PPTA welcomes the revision of the EU pharmaceutical legislation as an opportunity to improve access to therapies, including life-saving plasma-derived medicinal products (PDMPs) for EU patients. A revised framework has the potential to provide a robust set of provisions that will continue to ensure the safety and quality of human plasma used for manufacturing, while upholding the safety, quality, and efficacy of PDMPs.
All
PPTA statements
PPTA Statement on the Revision of the General EU Pharmaceutical Legislation
PPTA welcomes the revision of the EU pharmaceutical legislation as an opportunity to improve access to therapies, including life-saving plasma-derived medicinal products (PDMPs) for EU patients. A revised framework has the potential to provide a robust set of provisions that will continue to ensure the safety and quality of human plasma used for manufacturing, while upholding the safety, quality, and efficacy of PDMPs.
All
PPTA statements
Announcing PPTA’s New Global Chair
It is with great pleasure that the Plasma Protein Therapeutics Association (PPTA) announces the election of Giles Platford from Takeda to the Chair of the PPTA Global Board.
All
PPTA statements
Announcing PPTA’s New Global Chair
It is with great pleasure that the Plasma Protein Therapeutics Association (PPTA) announces the election of Giles Platford from Takeda to the Chair of the PPTA Global Board.
All
PPTA statements
No results found